Miramar Capital, LLC Intra Cellular Therapies, Inc. Transaction History

Miramar Capital, LLC

  • $428 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$43.8 - $56.99 $24,309 - $31,629
555 Added 2.52%
22,550 $1.22 Million
Q3 2022

Nov 10, 2022
SELL
$42.7 - $59.99 $290,360 - $407,932
-6,800 Reduced 23.62%
21,995 $1.1 Million
Q2 2022

Aug 03, 2022
BUY
$43.0 - $65.64 $15,050 - $22,974
350 Added 1.23%
28,795 $1.64 Million
Q1 2022

May 10, 2022
BUY
$38.74 - $62.09 $1.1 Million - $1.77 Million
28,445 New
28,445 $1.74 Million

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.85B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Miramar Capital, LLC Portfolio

Follow Miramar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miramar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miramar Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email